Clinical Trial 55836

North Ridge, CA 91325


Atopic Dermatitis (Eczema) - North Ridge CA
Click image to enlarge

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab monotherapy by subcutaneous injection in participants aged 18 years and older with moderate-to-severe atopic dermatitis.


Participants must be at least 18 years of age inclusive, at the time of signing the informed consent.

Must be Diagnosed with 

Participants must have documented history within 6 months prior to screening visit, of either inadequate response or inadvisability of topical treatments

Qualified Participants May Receive:

Preliminary Assessment at No Cost

No Cost Medication

Possible Eczema Treatment

Compensation for Time and Travel - Up to $3,000


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.